Regarding bolus insulin treatment, individuals with LADA had the highest percentage of bolus insulin prescription (72.1%), followed by T1DM (71.3%), T2DM (10.1%) and GDM (2.6%), with more fCGM users being prescribed bolus insulin than those who perform BGM in all types of diabetes, except LADA. This evidence concerns the gene INS and type 1 diabetes mellitus.